TherOx Completes Enrollment in Study of Next-Generation Therapy System Designed to Improve AMI Outcomes

Autor:	TherOx, Inc.
Zdroj:	Business Wire (English). 05/03/2017.
Abstrakt:	TherOx, Inc., a privately held medical device company focused on improved treatment of Acute Myocardial Infarction (AMI), announced that it completed enrollment in the IC-HOT (Evaluation of Intracoronary Hyperoxemic Oxygen Therapy) study. IC-HOT is a confirmatory study of the second-generation TherOx system that delivers Supersaturated Oxygen (SSO2) Therapy for reduction of infarct size after an AMI. [ABSTRACT FROM PUBLISHER]
Databáze:	Regional Business News
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.